Efficacy and safety of a smartphone application‐based treatment of ketogenic diet in pediatric refractory epilepsy

Author:

Li Wei1ORCID,Gu Wei1,Liang Chao2,Tu Fulai3,Ding Le2,Lu Xiaopeng2,Guo Hu2,Zheng Guo2,Wu Chunfeng2

Affiliation:

1. Department of Clinical Research Center Children's Hospital of Nanjing Medical University Nanjing China

2. Department of Neurology Children's Hospital of Nanjing Medical University Nanjing China

3. Key Laboratory of Environmental Medicine Engineering, Department of Epidemiology and Health Statistics, School of Public Health Southeast University Nanjing China

Abstract

AbstractObjectiveWe aimed to find predictors for smartphone application‐based ketogenic diet (KD) treatment effectiveness and safety.MethodsThe efficacy was evaluated according to the reduction in seizure frequency after the intervention of KD; safety was evaluated based on adverse effects. The ordinal logistic regression analysis was used to explore the influencing factors of efficacy.ResultsThe study sample included 116 males and 65 females with a median age of 2.27 years. The baseline frequency of seizure was more than five times/day in 123 children, 50.83% of them received three or more antiepileptic drugs (AEDs). Seventy‐two patients' KD initiation mode was outpatient, and 73 completed the 12‐month follow‐up. A total of 88 (48.62%) patients had reported a reduction in seizure ≥50%. Compared with 12 months, those who had received KD therapy for only 3 (P = 0.009) and 6 months (P = 0.005) were more likely to show negative outcomes. Outpatient initiation had better outcomes (P = 0.029) than inpatient initiation. For the number of AEDs applied, patients on two AEDs were more likely to achieve better outcomes (P = 0.001). Adverse events had been noted among 77 patients; BMI Z‐score at KD initiation was associated with adverse effects (P = 0.003).SignificanceOur study suggested that outpatient initiation and long‐term treatment of KD should be encouraged.Plain Language SummaryOur research shows that the KD is a helpful treatment for children with refractory epilepsy, reducing seizures by more than 50% in nearly half of the cases, with some experiencing complete seizure freedom. We used a smartphone app to improve communication between patients and their healthcare teams, resulting in a high retention, and app usage was linked to reduced adverse effects. We recommend early consideration of KD treatment for patients failing two AED, encourage outpatient initiation, and advocate for longer‐term KD use.

Funder

Jiangsu Commission of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3